Lisa Walter

Stock Analyst at RBC Capital

(2.33)
# 2,704
Out of 5,042 analysts
5
Total ratings
50%
Success rate
14.68%
Average return

Stocks Rated by Lisa Walter

4D Molecular Therapeutics
Oct 21, 2025
Reiterates: Outperform
Price Target: $26
Current: $11.34
Upside: +129.28%
United Therapeutics
Sep 26, 2025
Initiates: Outperform
Price Target: $569
Current: $418.58
Upside: +35.94%
Viridian Therapeutics
Aug 7, 2025
Maintains: Outperform
Price Target: $45$41
Current: $22.16
Upside: +85.02%
Apellis Pharmaceuticals
Aug 1, 2025
Maintains: Sector Perform
Price Target: $17$19
Current: $28.17
Upside: -32.55%
EyePoint Pharmaceuticals
Jun 17, 2025
Initiates: Outperform
Price Target: $28
Current: $11.98
Upside: +133.72%